Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin Plus Ezetimibe vs High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus
KCT0010164Phase 4Not yet recruiting
- Sponsor
- Daewon Pharm
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pitavastatin, ezetimibe in atherosclerotic disease, sponsored by Daewon Pharm. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
pitavastatinezetimibe
03
Conditions
atherosclerotic disease
Beyond the preview
Go deeper on KCT0010164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010164.